drugset / Trial / NCT00158769
A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This compound, GR270773, is a lipid based compound being developed to treat Sepsis. Lipids are broken down in the body by the liver. This study is designed to see whether the effect of the drug in people with poorly functioning livers is any different to the effect on healthy adults.
Timeline
- Start
- 2005-03-31
- Primary completion
- 2005-10-26
- Completion
- 2005-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GR270773 | Unknown | 5 mg/kg | Intravenous |
| Subject | GR270773 | Unknown | 12.5 mg/kg | Intravenous |